Tristel Sets 2 March Date for Interim Results and Investor Briefings

Tristel ( (GB:TSTL) ) has issued an update.

Tristel plc has announced that it will publish its interim results for the six months to 31 December 2025 on 2 March 2026, and has scheduled a series of briefings for analysts and investors in London and online on the same day. Management will host both a live online presentation via the Investor Meet Company platform and an in-person session in the City of London, signalling an active engagement with shareholders and the market as it updates on trading performance and execution of its growth strategy in the infection prevention sector.

The most recent analyst rating on (GB:TSTL) stock is a Buy with a £478.00 price target. To see the full list of analyst forecasts on Tristel stock, see the GB:TSTL Stock Forecast page.

Spark’s Take on GB:TSTL Stock

According to Spark, TipRanks’ AI Analyst, GB:TSTL is a Outperform.

Tristel’s strong financial performance and positive earnings call outlook are the primary drivers of its stock score. While technical indicators suggest caution due to overbought conditions, the company’s strategic expansion and dividend increase support a favorable long-term view. Valuation concerns are mitigated by the company’s growth prospects.

To see Spark’s full report on GB:TSTL stock, click here.

More about Tristel

Tristel plc is a global infection prevention company specialising in proprietary chlorine dioxide-based chemistry for the manual decontamination of medical devices and sporicidal surface disinfection. Operating from its head office and manufacturing site near Cambridge, the AIM-listed group employs around 270 staff across 16 subsidiaries and sells into more than 40 countries, targeting double-digit annual revenue growth, robust cash generation, and progressive dividends.

Average Trading Volume: 136,147

Technical Sentiment Signal: Strong Buy

Current Market Cap: £204.6M

For an in-depth examination of TSTL stock, go to TipRanks’ Overview page.